Aurobindo Pharma Limited – NSE:AUROPHARMA.NS

Aurobindo Pharma Limited stock price today

INR 732.1
-537.85
-42.35%
Financial Health
0
1
2
3
4
5
6
7
8
9

Aurobindo Pharma Limited stock price monthly change

-4.29%
month

Aurobindo Pharma Limited stock price quarterly change

-4.29%
quarter

Aurobindo Pharma Limited stock price yearly change

+18.73%
year

Aurobindo Pharma Limited key metrics

Market Cap
 727.71B
Enterprise value
 782.82B
P/E
 20.70
EV/Sales
 2.60
EV/EBITDA
 11.55
Price/Sales
 2.45
Price/Book
 2.40
PEG ratio
 0.05
EPS
 54.15
Revenue
 287.92B
EBITDA
 62.74B
Income
 31.72B
Revenue Q/Q
 18.83%
Revenue Y/Y
 16.96%
Profit margin
 11.91%
Oper. margin
 20.27%
Gross margin
 48.94%
EBIT margin
 20.27%
EBITDA margin
 21.79%

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Aurobindo Pharma Limited stock price history

Aurobindo Pharma Limited stock forecast

Aurobindo Pharma Limited financial statements

Profit Margin

Aurobindo Pharma Limited (NSE:AUROPHARMA.NS): Profit margin
Jun 2023 67.90B 5.70B 8.4%
Sep 2023 71.50B 7.57B 10.59%
Dec 2023 72.71B 9.36B 12.88%
Mar 2024 75.80B 9.08B 11.99%
AUROPHARMA.NS income statement history

Aurobindo Pharma Limited Financials Estimate

Aurobindo Pharma Limited (NSE:AUROPHARMA.NS): Analyst Estimates
2026 346.05B 45.38B 13.11%
2027 357.50B 45.86B 12.83%

  • Analysts Price target

  • Financials & Ratios estimates

Show more
0.11%
Yield TTM
Aurobindo Pharma Limited (NSE:AUROPHARMA.NS): Payout ratio
Payout ratio 0%
Aurobindo Pharma Limited (NSE:AUROPHARMA.NS): Dividend Yield
2016 0.31%
2017 0.29%
2019 0.31%
2020 0.78%
2022 0.67%
AUROPHARMA.NS dividends history

Debt to Assets

Aurobindo Pharma Limited (NSE:AUROPHARMA.NS): Debt to assets
Jun 2023 0 0
Sep 2023 439235900000 157.29B 35.81%
Dec 2023 0 0
Mar 2024 450715100000 152.20B 33.77%
AUROPHARMA.NS balance sheet history

Cash Flow

Aurobindo Pharma Limited (NSE:AUROPHARMA.NS): Cash Flow
Mar 2023 -57.5M 0 0
Jun 2023 6.53B 0 0
Sep 2023 15.00B -30.61B 12.92B
Dec 2023 8.46B 0 0
AUROPHARMA.NS cash flow history

Aurobindo Pharma Limited alternative data

Aurobindo Pharma Limited
Employees

Aurobindo Pharma Limited (NSE:AUROPHARMA.NS): Employee count
Aug 2023 15,431
Sep 2023 23,451
Oct 2023 23,451
Nov 2023 23,451
Dec 2023 23,451
Jan 2024 23,451
Feb 2024 23,451
Mar 2024 23,451
Apr 2024 23,451
May 2024 23,451
Jun 2024 23,451
Jul 2024 23,451

Aurobindo Pharma Limited other data

Aurobindo Pharma Limited
Executives

Insider Compensation
Mr. Mettu Madan Mohan Reddy (1960) Whole-Time Director
 $52,340,000
Dr. Meenakshi Sunderam Sivakumaran (1943) Whole-Time Director
 $23,310,000
Mr. Kambam Nithyananda Reddy (1958) Vice Chairman & Whole-Time Director
 $23,300,000
Mr. Penaka Sarath Chandra Reddy (1985) Whole-Time Director
 $14,600,000

Frequently Asked Questions (FAQ)

  • What's the price of Aurobindo Pharma Limited stock today?

    One share of Aurobindo Pharma Limited stock can currently be purchased for approximately $732.1.

  • When is Aurobindo Pharma Limited's next earnings date?

    Unfortunately, Aurobindo Pharma Limited's (AUROPHARMA.NS) next earnings date is currently unknown.

  • Does Aurobindo Pharma Limited pay dividends?

    Yes, Aurobindo Pharma Limited pays dividends and its trailing 12-month yield is 0.12% with 0% payout ratio. The last Aurobindo Pharma Limited stock dividend of $0 was paid on 12 Sep 2025.

  • How much money does Aurobindo Pharma Limited make?

    Aurobindo Pharma Limited has a market capitalization of 727.71B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 24.12% to 290.02B US dollars.

  • What is Aurobindo Pharma Limited's stock symbol?

    Aurobindo Pharma Limited is traded on the NSE under the ticker symbol "AUROPHARMA.NS".

  • What is Aurobindo Pharma Limited's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.

  • How do i buy shares of Aurobindo Pharma Limited?

    Shares of Aurobindo Pharma Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Aurobindo Pharma Limited's key executives?

    Aurobindo Pharma Limited's management team includes the following people:

    • Mr. Mettu Madan Mohan Reddy Whole-Time Director(age: 65, pay: $52,340,000)
    • Dr. Meenakshi Sunderam Sivakumaran Whole-Time Director(age: 82, pay: $23,310,000)
    • Mr. Kambam Nithyananda Reddy Vice Chairman & Whole-Time Director(age: 67, pay: $23,300,000)
    • Mr. Penaka Sarath Chandra Reddy Whole-Time Director(age: 40, pay: $14,600,000)

  • How many employees does Aurobindo Pharma Limited have?

    As Jul 2024, Aurobindo Pharma Limited employs 23,451 workers.

  • When Aurobindo Pharma Limited went public?

    Aurobindo Pharma Limited is publicly traded company for more then 29 years since IPO on 15 Jan 1996.

  • What is Aurobindo Pharma Limited's official website?

    The official website for Aurobindo Pharma Limited is aurobindo.com.

  • How can i contact Aurobindo Pharma Limited?

    Aurobindo Pharma Limited can be reached via phone at +91 40 6672 5000.

Aurobindo Pharma Limited company profile:

Aurobindo Pharma Limited

aurobindo.com
Exchange:

NSE

Full time employees:

26,015

Industry:

Drug Manufacturers - Specialty & Generic

Sector:

Healthcare

Aurobindo Pharma Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients, generic pharmaceuticals, and related services in India. The company primarily offers oral solids, injectables, and over-the-counter drugs, as well as active pharmaceutical ingredients and finished dosage forms for cardiovascular, central nervous system, gastroenterology, anti-allergies, anti-diabetics, anti-retroviral, antibiotics, dermatology, respiratory, and oncology. It is also involved in the development of a product pipeline in biosimilar and vaccine segments; and custom research and manufacturing activities for the bio-tech and pharmaceutical community. In addition, the company develops and manufactures peptides, as well as biocatalysts for use in the pharmaceutical and chemical industries. Further, it is developing biosimilar, inhalers, transdermal patches, vaccines, topicals, and depot injections. The company also exports its products. It serves multinational companies. The company has an agreement with COVAXX to develop and commercialize COVID-19 Vaccine for India and UNICEF. Aurobindo Pharma Limited was incorporated in 1986 and is headquartered in Hyderabad, India.

+91 40 6672 5000
Galaxy, Plot No. 1
Hyderabad, 500032

:
ISIN: INE406A01037
CUSIP: Y04527142